Is It Still Safe To Buy Aviva Plc?

In this strong market, should you still buy Aviva plc (LON: AV)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m always searching for shares that can help ordinary investors like you make money from the stock market. However, many people are currently worried the market has been overheating.

So right now I’m analysing some of the most popular companies in the FTSE 100, hoping to establish if they can continue to outperform in today’s uncertain economy.

Today I’m looking at insurer Aviva (LSE: AV) (NYSE: AV.US) to determine whether the shares are still safe to buy at 367p.

So, how’s business going?

Aviva is currently undertaking a huge turnaround programme aimed at cutting costs, reducing the group’s exposure to Europe and simplifying the company’s overall structure.

Indeed, it would appear that the company is already making progress, as within Aviva’s first-quarter management statement, the company noted that operating expenses had fallen by £83m or 10% year-on-year — more than 20% of the company’s total targeted cost saving of £400m.

In addition, during the same three-month period, Aviva reduced internal debt by £300m and the value of new business taken on by the company rose 18%.

Furthermore, in an attempt to simplify the business, four levels of middle management were removed. 

That said, Aviva’s operations within southern Europe continued to show weakness and the value of business written in Spain and Italy dropped 67% and 56% respectively during the quarter.

Expected growth

Unfortunately, Aviva reported a loss during 2012 but many City analysts expect the company’s earnings to rebound this year. City forecasts currently predict earnings of 41.4p per share for this year (up from -15.2p during 2012) and 46.4p for 2014.

Shareholder returns

Aviva was well known for its larger-than-average dividend yield; however, the company was forced to cut its payout earlier this year, citing cash flow problems.

Still, even after the dividend cut, Aviva supports a yield of 5.2% — larger than that of its peers in the life insurance sector, which currently offer an average dividend yield of 3.7%.

Valuation

As Aviva made a loss during 2012, it is not possible for me to calculate a historic P/E for the company.

Having said that, based on estimates for future earnings, I believe the group is currently trading at a forward P/E ratio of 8.7, cheaper than the company’s peers in the life insurance sector, which are currently trading at a historic P/E of around 14.1.

Foolish summary

All in all, based on the company’s progress during the first quarter of this year, above average dividend yield and discount to sector peers, I feel that Aviva still looks safe to buy at 367p.

More FTSE opportunities

As well as Aviva, I am also positive on the five FTSE shares highlighted within this exclusive wealth report.

Indeed, all five opportunities offer a mix of robust prospects, illustrious histories and dependable dividends, and have just been declared by the Fool as “5 Shares You Can Retire On“!

Just click here for the report — it’s free.

In the meantime, please stay tuned for my next FTSE 100 verdict

> Rupert does not own any share mentioned in this article.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 21% and yielding 10%, is this income stock a top contrarian buy now?

Despite its falling share price, this Fool reckons he's found an income stock that could be worth taking a closer…

Read more »

Investing Articles

The Meta share price falls 10% on weak Q2 guidance — should investors consider buying?

The Meta Platforms' share price is down 10% after the company reported Q1 earnings per share growth of 117%. Does…

Read more »